P. Effert

发表

Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose.

G Jakse, G. Jakse, R. Bares, 1996, The Journal of urology.

p53 gene alterations in human prostate carcinoma.

E. Liu, P. Walther, P. Effert, 1993, The Journal of urology.

Alterations of the p53 gene in nasopharyngeal carcinoma

T. Tursz, Q. Zhang, N. Raab-Traub, 1992, Journal of virology.

Prevalence of human papillomavirus types 16 and 18 in squamous‐cell carcinoma of the penis: A retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction

P. Humphrey, E. Liu, J. Wiener, 1992, International journal of cancer.

FDG PET for detection and therapy control of metastatic germ cell tumor.

O. Sabri, G. Jakse, U. Cremerius, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical use of prostate-specific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostate.

G. Jakse, J. Wolff, P. Effert, 1996, European urology.

Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction.

E. Liu, A. Neubauer, P. Walther, 1992, The Journal of urology.

Analysis of gene amplification in archival tissue by differential polymerase chain reaction.

A. Neubauer, M. He, R. A. Frye, 1992, Oncogene.

Invasive Potential of “Noninvasive” Human Bladder Carcinoma

P. Effert, P. Seifert, 2003 .

Invasive potential of "noninvasive" human bladder carcinoma. An electron microscopy study.

P. Effert, P. Seifert, 2003, American journal of clinical pathology.

Nerve fibers in tumors of the human urinary bladder

P. Effert, P. Seifert, M. Benedic, 2002, Virchows Archiv.

Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly.

S. Braun, B. Gunawan, L. Füzesi, 1998, Cancer genetics and cytogenetics.

Expression of the matrix Gla protein in urogenital malignancies

E. Liu, T. Strohmeyer, E. Levedakou, 1992, International journal of cancer.

Current and future strategies to block tumor angiogenesis, invasion, and metastasis

T. Strohmeyer, G. Gastl, P. Effert, 2004, World Journal of Urology.

Primary adenocarcinoma of the seminal vesicles.

P. Effert, R. Thiel, 2002, The Journal of urology.

Evaluation of patients with diseases of the prostate using prostate-specific antigen density

G. Jakse, J. Wolff, P. Effert, 1995 .

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma.

E. Liu, A. Neubauer, P. Walther, 1992, The Journal of urology.

Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.

G. Bartsch, P. Effert, D. Strohmeyer, 2004, Anticancer research.

Theories on the metastatic process and possible therapeutic options

T. Strohmeyer, P. Effert, 2004, Urological Research.

Changes of renal blood flow in nephroptosis: assessment by color Doppler imaging, isotope renography and correlation with clinical outcome after laparoscopic nephropexy.

G. Bartsch, F. Frauscher, P. Effert, 2004, European urology.

Laparoscopic bilateral ureterolysis in Ormond's disease.

G. Jakse, J. Wolff, P. Effert, 1996, Urologia internationalis.

Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma.

G. Jakse, Y. Tamimi, P. Effert, 2004, Anticancer research.

Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia.

F. Habib, H. Borchers, G. Jakse, 1996, British journal of urology.

Basic research in prostate cancer: molecular biology.

T. Strohmeyer, P. Effert, 1994, Acta urologica Belgica.